Medecins Sans Frontieres TasP
Status:Ongoing
Phase:Open Label
Principal Investigator(s):
Objective:Feasibility and acceptibility of early ART and other preventative interventions
Prevention Option(s):Treatment U=U
Study Design:
Trial Sponsors:
MSF, South Africa Department of Health
Start Date
End Date
April 3, 2014
none
Enrollment:0
Age range:
↔
any
Population:Cisgender Men, Cisgender Women, People Living with HIV